1 April 2020
Sitryx signs potential $880m drug development deal
UK-based biopharmaceutical firm Sitryx has entered into a licensing and research agreement with Eli Lilly to develop new disease-modifying drugs.
Focus:
News
-
-
1 April 2020
Neurimmune and Ethris to develop mRNA antibody for Covid-19
Swiss biopharmaceutical firm Neurimmune has partnered with German biotechnology company Ethris to develop mRNA-based, neutralising antibodies for Covid-19 treatment.
-
1 April 2020
FDA launches new programme to speed-up Covid-19 therapies
The US Food and Drug Administration (FDA) has launched a new programme aimed at accelerating the development of potential treatments for Covid-19 infection.
-
31 March 2020
Cobra Biologics, Karolinska Institutet partner on Covid-19 vaccine
Cobra Biologics has partnered with the Karolinska Institutet in Sweden to develop a potential DNA vaccine candidate for the novel coronavirus, SARS-CoV-2.
-
31 March 2020
Aptorum and Covar explore repurposed drugs for coronavirus
Aptorum Group is set to choose at least three repurposed drug candidates for Covid-19 treatment, out of nearly 2,600 approved small drug molecules screened using its Smart-ACT drug discovery platform.
-
31 March 2020
GigaGen works on recombinant polyclonal antibody against Covid-19
Biotechnology company GigaGen is working on a recombinant polyclonal antibody, referred to as recombinant anti-coronavirus 19 hyperimmune gammaglobulin (rCIG), as a Covid-19 treatment.
-
31 March 2020
FDA approves Lilly’s plaque psoriasis drug Taltz for children
The US Food and Drug Administration (FDA) has approved Eli Lilly’s Taltz (ixekizumab) to treat moderate to severe plaque psoriasis in children aged six to below 18 years.
-
31 March 2020
Noveome studies anti-inflammatory drug ST266 in Covid-19
Next generation biologics company Noveome Biotherapeutics will evaluate its lead programme ST266 as a potential treatment of severe cytokine storm response associated with Covid-19.
-
31 March 2020
US HHS expedites development and manufacture of Covid-19 vaccines
The US Department of Health and Human Services (HHS) is accelerating the development and manufacturing of vaccine against the Covid-19 coronavirus infection.
-
31 March 2020
US urges India to lift export ban on pharmaceutical ingredients
Officials of the US have asked India to lift the ban imposed on export of pharmaceutical ingredients amid the Covid-19 coronavirus pandemic.
Close
Close
Close
Go Top